( May 23, 2025, 12:53 PM EDT) -- WASHINGTON, D.C. — The Ninth Circuit U.S. Court of Appeals erred in finding that a stem cell mixture used by clinics is a drug under the U.S. Federal Food, Drug, and Cosmetic Act (FDCA), a stem cell clinic and its owners tell the U.S. Supreme Court in a petition for a writ of certiorari....